Investment
Features
FeesSafety
Academy
More
Pluang+

AC Immune keeps Buy rating on strong Parkinson’s and Alzheimer’s drug progress, cash runway to late 2027

Analyst Insights
24 Sep 2026
Seeking Alpha
View Source
Bullish
AC Immune keeps Buy rating on strong Parkinson’s and Alzheimer’s drug progress, cash runway to late 2027

AC Immune maintains a Buy rating following positive 100-week safety and immune response data for its Parkinson’s drug ACI-7104. Progress in its pipeline includes a $12 million milestone triggered by ACI-24 for early Alzheimer’s, which showed antibody responses at all doses. Another drug, ACI-19764, targeting neuroinflammatory and metabolic disorders, is expected to release early phase data by late 2026. The company’s cash runway extends into Q4 2027, though additional funding may be needed beyond that to continue operations.

AC Immune updates on drug progress and pipeline expansions. For readers following the health sector, here is Pluang's market snapshot as of Sep 25, 2026 02:11 WIB: 51 of 100 health stocks rose, 48 fell. Notable movers include Illumina (ILMN) at USD 273.90 with a 7.25% increase and 69% buy orders, Moderna (MRNA) at USD 194.32 up 6.70% with 87% sell orders, and Oscar Health (OSCR) at USD 28.85 down 5.50% with nearly balanced buy/sell activity.

More News

Costco beats Q4 EPS estimates with $6.75 despite slight revenue miss, driven by strong sales growth and tariff refunds.

Costco beats Q4 EPS estimates with $6.75 despite slight revenue miss, driven by strong sales growth and tariff refunds.

Costco reported a strong Q4 earnings per share (EPS) of $6.75, surpassing analyst expectations of $6.54, helped by tariff refunds. Although quarterly revenue of $93.87 billion slightly missed the $94.97 billion forecast, net sales rose 11.2% year-ove...

Company Fundamentals
Bullish
1 hour ago
Vistry Group cuts profit forecast after £661m H1 loss and plans strategic downsizing.

Vistry Group cuts profit forecast after £661m H1 loss and plans strategic downsizing.

Vistry Group reported a significant first-half pre-tax loss of £661.3 million, driven by a £475 million goodwill impairment and increased building safety costs. Revenue fell to £1.42 billion, and operational performance weakened with fewer home compl...

Company Fundamentals
Bearish
2 hours ago
Vail Resorts expects a loss with flat revenue in upcoming Q3 earnings report on Sept 28, 2026.

Vail Resorts expects a loss with flat revenue in upcoming Q3 earnings report on Sept 28, 2026.

Vail Resorts is set to report its Q3 2026 earnings on September 28, with analysts forecasting a loss per share around -$5.30 and revenue near $271 million, indicating flat performance year-over-year. The company’s financial health shows a high Debt-t...

Company Fundamentals
Bearish
2 hours ago
Western Union shares drop amid analyst downgrades and earnings pressure

Western Union shares drop amid analyst downgrades and earnings pressure

Western Union faces multiple analyst downgrades with price targets cut to as low as $6.00, reflecting concerns over its profitability and competitive pressures from fintech rivals. The stock has fallen over 15% in the past month, trading near $6.00, ...

Market News
Bearish
3 hours ago
Bitget halts withdrawals after $351.6M unauthorized crypto transfer, marking a major September exploit.

Bitget halts withdrawals after $351.6M unauthorized crypto transfer, marking a major September exploit.

Bitget exchange stopped withdrawals after detecting an unauthorized transfer of about $351.6 million from its hot and warm wallets. The company confirmed that its cold wallets remained secure and trading continued unaffected. Bitget's User Protection...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App